Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1), was initially described as autoantigen p271,2, and discovered in the late 1990s as a novel autoantigen overexpressed in Sjögrens syndrome and/or scleroderma patients1. This evidence concerns the gene ZNRD2 and scleroderma.